Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies
Myelodysplastic syndrome (MDS) is a heterogeneous hematological malignancy, characterized by cytopenia and accompanied by a risk of transformation into acute myeloid leukemia (AML). Epidemiological studies for decades have shown association between autoimmune diseases (AIDs) and MDS. Specifically, patients with antecedent AIDs tends to have an increased risk of developing MDS, and these patients display different clinical characteristics and outcomes. Importantly, immune dysregulation has been the common driving force between MDS and AIDs pathogenesis.
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Cong Wang, Yan Yang, Sujun Gao, Jingcheng Chen, Jinyuan Yu, Han Zhang, Mingxi Li, Xingying Zhan, Wei Li Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Autoimmune Disease | Cancer & Oncology | Epidemiology | Hematology | HIV AIDS | Leukemia | Myelodysplastic Syndrome | Study